Toucan Capital

Toucan Capital Fund II, L.P. is a $140 million venture capital fund focused on seed and early-stage life science and advanced technology investments. Toucan Capital Corp. launched its first fund in 1997 and began investing its current fund in August of 2001. Toucan invests nationwide and is one of the largest and most active venture capital funds in seed and early-stage life science. Toucan has also been an early investor in nanotechnology. Toucan is especially active in the mid-Atlantic region, one of the richest markets in the country for life science and certain advanced technologies, and a market that has generally been underserved by venture capital.

Powers J.D., Linda F.

Co-Founder and Managing Director and Partner

8 past transactions

INmuneBIO

Post in 2019
INmune Bio is a clinical-stage immuno-oncology company focused on harnessing the patient’s immune system to treat cancer. INKmune, the company’s lead product, primes patient’s NK cells (natural killer cells) to kill cancer. INmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. By controlling residual disease, patients may live longer. Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells’ ability to eliminate residual disease.

Reactive NanoTechnologies

Series D in 2008
Reactive NanoTechnologies develops and manufactures products to control the instantaneous release of heat energy for advanced joining applications. The company’s products are used in CPV, HB LED attach, power electronics, thermal management, and component mounting applications. Reactive NanoTechnologies was founded in 2001 and is based in Hunt Valley, Maryland.

Q Therapeutics

Venture Round in 2008
Q Therapeutics is a development stage company, engages in the development of human cell-based therapies for the treatment of degenerative diseases of the brain and spinal cord. The company develops Q-Cells that is intended for the treatment of amyotrophic lateral sclerosis, multiple sclerosis, transverse myelitis, traumatic spinal cord injury, and Parkinson’s disease, as well as for Alzheimer’s disease, traumatic brain injury, cerebral palsy, Leukodystrophies and central nervous system storage diseases, and peripheral neuropathies. Q Therapeutics is headquartered in Salt Lake City, Utah.

Reactive NanoTechnologies

Series C in 2008
Reactive NanoTechnologies develops and manufactures products to control the instantaneous release of heat energy for advanced joining applications. The company’s products are used in CPV, HB LED attach, power electronics, thermal management, and component mounting applications. Reactive NanoTechnologies was founded in 2001 and is based in Hunt Valley, Maryland.

Pepgen

Series D in 2004
Pepgen is a privately-held biopharmaceutical company that develops and commercializes novel products for the prevention and treatment of autoimmune and viral disorders. It was founded in 1992 by Chih-Ping Liu and is based in Alameda, California.

Intrapace

Series C in 2004
IntraPace® has developed a novel implantable system to treat obesity. It is built on the proven technology used in millions of cardiac pacemakers and defibrillators each year. The abiliti® system is designed to be implanted via standard laparoscopic instruments without making any changes to the anatomy of the digestive system or placing any limitations on what a person can eat or drink.

Reactive NanoTechnologies

Series B in 2004
Reactive NanoTechnologies develops and manufactures products to control the instantaneous release of heat energy for advanced joining applications. The company’s products are used in CPV, HB LED attach, power electronics, thermal management, and component mounting applications. Reactive NanoTechnologies was founded in 2001 and is based in Hunt Valley, Maryland.

Reactive NanoTechnologies

Series A in 2003
Reactive NanoTechnologies develops and manufactures products to control the instantaneous release of heat energy for advanced joining applications. The company’s products are used in CPV, HB LED attach, power electronics, thermal management, and component mounting applications. Reactive NanoTechnologies was founded in 2001 and is based in Hunt Valley, Maryland.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.